{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T17:05:38Z","timestamp":1710781538104},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s11940-005-0015-1","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T18:57:22Z","timestamp":1181069842000},"page":"221-230","source":"Crossref","is-referenced-by-count":6,"title":["Myoclonus"],"prefix":"10.1007","volume":"7","author":[{"given":"Melissa J.","family":"Nirenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Frucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"15_CR1","doi-asserted-by":"crossref","unstructured":"Marsden CD, Hallett M, Fahn S: The nosology and pathophysiology of myoclonus. Mov Disord 1982:196\u2013248.","DOI":"10.1016\/B978-0-407-02295-9.50018-7"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11940-000-0006-1","volume":"2","author":"S Frucht","year":"2000","unstructured":"Frucht S: Myoclonus. Curr Treat Options Neurol 2000, 2:231\u2013241.","journal-title":"Curr Treat Options Neurol"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","volume":"3","author":"JN Caviness","year":"2004","unstructured":"Caviness JN, Brown P: Myoclonus: current concepts and recent advances. Lancet Neurol 2004, 3:598\u2013607.","journal-title":"Lancet Neurol"},{"key":"15_CR4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1212\/01.WNL.0000121228.32913.00","volume":"62","author":"K Easterford","year":"2004","unstructured":"Easterford K, Clough P, Kellett M, et al.: Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology 2004, 62:1435\u20131437. This is a recent study of 50 consecutive patients treated with valproic acid. Parkinsonism occurred in three patients, and resolved in the two from whom it was subsequently with-drawn. Beta-CIT-SPECT was normal in all three patients. The findings suggest that reversible parkinsonism may be a more common side effect of valproic acid treatment than generally is recognized.","journal-title":"Neurology"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0022-510X(96)00244-4","volume":"145","author":"SM Baig","year":"1997","unstructured":"Baig SM: Acetazolamide therapy improves action myoclonus in Ramsay Hunt Syndrome. J Neurol Sci 1997, 145:123\u2013124.","journal-title":"J Neurol Sci"},{"key":"15_CR6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/jnnp.48.12.1304-a","volume":"48","author":"MG Goetting","year":"1985","unstructured":"Goetting MG: Catamenial exacerbation of action myoclonus: successful treatment with acetazolamide. J Neurol Neurosurg Psychiatry 1985, 48:1304\u20131305.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/jnnp.64.3.344","volume":"64","author":"M Koskiniemi","year":"1998","unstructured":"Koskiniemi M, Van Vleymen B, Hakamies L, et al.: Piracetam relieves symptoms in progressive myoclo-nus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo. J Neurol Neurosurg Psychiatry 1998, 64:344\u2013348. This large, randomized, controlled trial showed the safety and efficacy of piracetam in the treatment of progressive myoclo-nus epilepsy caused by Unverricht-Lundborg disease.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/mds.870110615","volume":"11","author":"A Ikeda","year":"1996","unstructured":"Ikeda A, Shibasaki H, Tashiro K, et al.: Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus\/ Piracetam Study Group. Mov Disord 1996, 11:691\u2013700.","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"15_CR9","first-page":"49","volume":"32","author":"P Genton","year":"1999","unstructured":"Genton P, Guerrini R, Remy C: Piracetam in the treatment of cortical myoclonus. Pharmacopsychiatry 1999, 32(Suppl 1):49\u201353.","journal-title":"Pharmacopsychiatry"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, et al.: The synaptic vesicle protein SV2A is the binding site for the anti-epileptic drug levetiracetam. Proc Natl Acad Sci U S A 2004, 101:9861\u20139866.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/jnnp.73.4.457","volume":"73","author":"SC Keswani","year":"2002","unstructured":"Keswani SC, Kossoff EH, Krauss GL, Hagerty C: Amelioration of spinal myoclonus with levetiracetam. J Neurol Neurosurg Psychiatry 2002, 73:457\u2013458. The authors reported on three patients with spinal myoclonus of varying etiologies who improved with levetiracetam treatment.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"15_CR12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/WNL.56.3.411","volume":"56","author":"GL Krauss","year":"2001","unstructured":"Krauss GL, Bergin A, Kramer RE, et al.: Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology 2001, 56:411\u2013412. This is a report of three patients with post-hypoxic or post-encephalitic action myoclonus who responded to treatment with levetiracetam.","journal-title":"Neurology"},{"key":"15_CR13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1212\/WNL.57.6.1112","volume":"57","author":"SJ Frucht","year":"2001","unstructured":"Frucht SJ, Louis ED, Chuang C, Fahn S: A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology 2001, 57:1112\u20131114. This is an open-label trial in which three of five patients with cortical myoclonus had a symptomatic improvement (and no significant side effects) with levetiracetam treatment.","journal-title":"Neurology"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.0013-9580.2004.56902.x","volume":"45","author":"A Magaudda","year":"2004","unstructured":"Magaudda A, Gelisse P, Genton P: Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 2004, 45:678\u2013681.","journal-title":"Epilepsia"},{"issue":"Suppl 5","key":"15_CR15","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1111\/j.1528-1157.1999.tb00916.x","volume":"40","author":"IE Leppik","year":"1999","unstructured":"Leppik IE: Zonisamide. Epilepsia 1999, 40(Suppl 5):S23-S29.","journal-title":"Epilepsia"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0387-7604(01)00230-3","volume":"23","author":"SJ Wallace","year":"2001","unstructured":"Wallace SJ: Newer antiepileptic drugs: advantages and disadvantages. Brain Dev 2001, 23:277\u2013283.","journal-title":"Brain Dev"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0920-1211(97)00069-7","volume":"29","author":"M Kyllerman","year":"1998","unstructured":"Kyllerman M, Ben-Menachem E: Zonisamide for pro-gressive myoclonus epilepsy: long-term observations in seven patients. Epilepsy Res 1998, 29:109\u2013114. This is a report of seven patients with progressive myoclonus epilepsy (due to Unverricht-Lundborg or Lafora Body disease) that responded to adjunctive therapy with zonisamide.","journal-title":"Epilepsy Res"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/mds.20217","volume":"19","author":"A Siniscalchi","year":"2004","unstructured":"Siniscalchi A, Mancuso F, Russo E, et al.: Spinal myoclonus responsive to topiramate. Mov Disord 2004, 19:1380\u20131381. This is a case report of a patient with spinal segmental myoclonus (in an amputation stump) who responded to treatment with topiramate.","journal-title":"Mov Disord"},{"key":"15_CR19","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1212\/WNL.54.8.1706","volume":"54","author":"A Priori","year":"2000","unstructured":"Priori A, Bertolasi L, Pesenti A, et al.: Gamma-hydroxy-butyric acid for alcohol-sensitive myoclonus with dystonia. Neurology 2000, 54:1706.","journal-title":"Neurology"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archneur.59.3.418","volume":"59","author":"G Defazio","year":"2002","unstructured":"Defazio G, Abbruzzese G, Girlanda P, et al.: Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 2002, 59:418\u2013420. This multicenter, retrospective case review reported on 65 patients, showing the safety and efficacy of botulinum toxin A in the treatment of hemifacial spasm.","journal-title":"Arch Neurol"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/mds.10038","volume":"17","author":"X Liu","year":"2002","unstructured":"Liu X, Griffin IC, Parkin SG, et al.: Involvement of the medial pallidum in focal myoclonic dystonia: A clinical and neurophysiological case study. Mov Disord 2002, 17:346\u2013353.","journal-title":"Mov Disord"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/jnnp.67.3.415","volume":"67","author":"A Kupsch","year":"1999","unstructured":"Kupsch A, Trottenberg T, Meissner W, Funk T: Neuro-stimulation of the ventral intermediate thalamic nucleus alleviates hereditary essential myoclonus. J Neurol Neurosurg Psychiatry 1999, 67:415\u2013416.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/mds.1119","volume":"16","author":"T Trottenberg","year":"2001","unstructured":"Trottenberg T, Meissner W, Kabus C, et al.: Neurostimu-lation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome. Mov Disord 2001, 16:769\u2013771.","journal-title":"Mov Disord"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-005-0015-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-005-0015-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-005-0015-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-005-0015-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T11:20:29Z","timestamp":1652613629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-005-0015-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1007\/s11940-005-0015-1","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}